Occult hepatitis C virus infection in a re-transplanted patient with liver failure of unknown etiology;Infección oculta por el virus de la hepatitis c en un paciente retrasplantado por falla hepática de origin desconocido

Revista Colombiana de Gastroenterologia

Volumn 25, Issue 1, 2010, Pages 76-85

  Cortés Mancera, Fabián M ^a,b   Restrepo, Juan Carlos ^a   Osorio, Germán ^a,c   Hoyos, Sergio ^a   Correa, Gonzalo ^a,d   Navas, María Cristina ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b INSTITUTO TECNOLÓGICO METROPOLITANO   (Colombia)

^c Hospital Universitario San Vicente de Paul   (Colombia)

^d HOSPITAL PABLO TOBÓN URIBE   (Colombia)

Author keywords

Genotype; Hepatic failure; Occult hepatitis C virus; RT PCR

Indexed keywords

EID: 77956976343     PISSN: 01209957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. WHO and VHPB. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration it the Viral Hepatitis Prevention Board, Antwerp, Belgium. Journal of Viral Hepatitis 1999; 6: 35-47.
2. Simmonds P. Viral heterogeneity of the hepatitis C virus. Journal of Hepatology 1999; 31(S1): 54-60.
3. Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. Journal of Molecular Biology 2001; 313(3): 451-64.
4. Rijnbrand, RC, Lemon SM. Internal ribosome entry site-mediated translation in hepatitis C virus replication. Current Topics in Microbiology and Immunology 2000; 242: 85-116.
5. Friebe P, Bartenschlager R. Genetic analysis of sequences in the 3'nontranslated region of hepatitis C virus that are important for RNA replication. Journal of Virology 2002; 76: 5326-5338.
6. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin T, Simmonds P, Smith D, Stuyver L, Weiner A. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Archives of Virology 1998; 143: 2493-2503.
7. Simmonds P, F McOmish, PL Yap, SW Chan, CK Lin, G Dusheiko, AA Saeed, EC Holmes. Sequence variability in the 5' noncoding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. Journal of General Virology 1993; 74: 661-668.
8. Davidson F, P Simmonds, JC Ferguson, LM Jarvis, BC Dow, EAC Follett, AJ Keller, T Kruisius C Lin, GA Medgyesu, H Kiyokawa, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5'non-coding region. Journal of General Virology 1995; 76: 1197-1204.
9. Zein NN, J Rakela, EL Krawitt KR Reddy, T. Tominaga, DH Persing, and the Collaborative Study Group. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy Annals of Internal Medicine 1996; 125: 634-639.
10. Nousbaum JB, S Pol, B Nalpas, P Landais, P Berthelot, C Brechot, and the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Annals of Internal Medicine 1995; 122: 161-168.
11. Takada NS, Takase A. Takada, and T. Date. Differences in the hepatitis C virus genotypes in different countries. Journal of Hepatology 1993; 17: 277-283.
12. Dehesa-Violante M, Bosques-Padilla F, Kershenobich- Stalnikowitz D; Mexican Study Group of Pegasys. Prevalence of hepatitis C virus genotypes in Mexican patients. Revista de Gastroenterología de México 2007; 72(4): 344-8.
13. Cristina J. Genetic diversity and evolution of hepatitis C virus in the Latin American region. Journal of Clinical Virology 2005; 34: S1-S7.
14. Gonzalo M, Mariela M, María FG, Katiuska G, Rodney C, Fernando LT, Lilia L, Ricardo R, Alejandro G S, María PM, Laura GA, Aura RM, Juan Cristina. Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American Region. Virology Journal 2007; 4: 79.
15. Rodríguez-Pérez F, Suárez-Pérez E, Álvarez-Rohena M, Toro DH. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico. Puerto Rico Health Sciences Journal 2004; 23(2 Suppl): 49-56.
16. Naoumov NZ, Rakela J, Krawitt EL. Hepatitis C virus genotypes in the United States. Epidemiology, pthogenicity, and response to interferon therapy Annals of Internal Medicine 1997; 126: 634-39.
17. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. PegInterferon alfa-2b plus ribavirin compared with Interferon alfa-2b plus ribavirin inicial treatment of chronic hepatitis C a randomized trial. Lancet 2001; 358: 958-65.
18. Friebe P, Bartenschlager R. Genetic analysis of sequences in the 3'nontranslated region of hepatitis C virus that are important for RNA replication. Journal of Virology 2002; 76: 5326-5338.
19. Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzett O M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM; PEGASYS International Study Group. PegInterferonalpha2a and ribavirin combination therapy in chronic hepatitis C a randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine 2004; 140: 346-55.
20. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodríguez-Inigo E, de Lucas S, Salas C, Jiménez-Heffernan JA, Perez-Mota A, Graus J, Lopez-Alcorocho JM, Carreño V. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189: 7-14.
21. Carreño V. Occult hepatitis C virus infection: A new form of hepatitis C. World J Gastroenterol 2006; 12(43): 6922-6925.
22. Carreño V, Castillo I, Bartolomé J, Rodríguez-Inigo E, Ortiz-Movilla N, de Lucas S, Pardo M. Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. J Clin Virol 2004; 31: 312-313.
23. Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 2009; 50(6): 1142-54.